Both stocks run through our valuation models. Here is how MEKICS Co (058110) and InBody Co.Ltd (041830) compare, as of Aug 20, 2026.
As of Aug 20, 2026, Fair Value Calculator sees InBody Co.Ltd as the more attractively valued of the two: MEKICS Co trades at KRW 1,784 versus a fair value of KRW 1,581 (-11%), while InBody Co.Ltd trades at KRW 62,000 versus KRW 74,549 (+20%).
MEKICS Co
058110.KQ · KRW · Health Care
-11%
upside to fair value
overvalued
PriceKRW 1,784
Fair ValueKRW 1,581
Quality45/100
InBody Co.Ltd
041830.KQ · KRW · Health Care
+20%
upside to fair value
undervalued
PriceKRW 62,000
Fair ValueKRW 74,549
Quality71/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
MEKICS CoInBody Co.Ltd
Valuation
—Dividend yield1.8%
Profitability
3%Net margin24%
-3%Operating margin24%
-1%Return on assets11%
Growth
-56%Revenue growth (YoY)18%
-26.8%Avg. growth/yr (3Y)13.5%
-30.2%Avg. growth/yr (5Y)16.9%
Balance & size
0.11×Debt / equity0.01×
$19MMarket cap$506M
weakGrowth qualityhealthy
InBody Co.Ltd leads: 0 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
MEKICS Coof which business quality 45 · market factors 28InBody Co.Ltdof which business quality 68 · market factors 81
ProfitabilityMargins and returns on capital today
5
59
Quality GrowthAre margins and returns improving?
67
45
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
100
51
Low VolatilityCalm price path (market factor)
50
43
MomentumPrice trend over the last 3–12 months (market factor)
21
98
52W MomentumDistance to the 52-week high (market factor)
14
97
Net IssuanceBuybacks instead of dilution
84
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
MEKICS Co
Asset-BasedKRW 1,584
1 of 1 models see the stock below the current price.
InBody Co.Ltd
DCF ModelsKRW 65,630
Earnings-BasedKRW 34,626
MultiplesKRW 44,543
Asset-BasedKRW 15,795
Growth DCFKRW 59,979
Economic ProfitKRW 32,522
Growth EarningsKRW 53,096
16 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
MEKICS Co
Bear KRW 1,180Fair Value KRW 1,581Bull KRW 2,360
KRW 1,784 = current price (white tick)
InBody Co.Ltd
Bear KRW 53,718Fair Value KRW 74,549Bull KRW 91,859
KRW 62,000 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
MEKICS Co · Health Care
Quality score45 · below median
Fair value upside-11% · above median
InBody Co.Ltd · Health Care
Quality score71 · Top 25%
Fair value upside+20% · Top 25%
Bottom line
As of Aug 20, 2026, Fair Value Calculator sees InBody Co.Ltd as the more attractively valued of the two: MEKICS Co trades at KRW 1,784 versus a fair value of KRW 1,581 (-11%), while InBody Co.Ltd trades at KRW 62,000 versus KRW 74,549 (+20%).
InBody Co.Ltd has the higher quality score (71/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
